rotation.to
Following this device: dark.
Free account
rotation.to
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

Who

David James Lennon

Chief Executive Officer

Company insider

Files Form 4 as: Chief Executive Officer, Whitehawk Therapeutics.

In numbers

Trades disclosed
45
Buys
0
Sells
8
Bought
$0
Sold
$2.1M
Companies
1
Companies where not an officer
0
First trade
2 Oct 2023
Last trade
15 Sep 2026
Last filed
18 Sep 2026

Companies traded

Where they are an officer
WHWK Whitehawk TherapeuticsDirector, Officer · Biotechnology · last 15 Sep 20260 buys · 8 sells

Activity over time

1 Nov 2024 – 1 Oct 2026
40Nov 24May 25Nov 25Apr 26Oct 26

Buys above the line, sells below, each month.

Every trade

TradedCompanyWhatAmount
15 Sep 2026filed 18 Sep 2026WHWK Whitehawk Therapeuticsoption or derivative · BiotechnologySEC FORM 4 Code A—193,957 at $0.00filing
15 Sep 2026filed 18 Sep 2026WHWK Whitehawk Therapeuticsoption or derivative · BiotechnologySEC FORM 4 Code A—193,957 at $0.00filing
15 Sep 2026filed 18 Sep 2026WHWK Whitehawk Therapeuticsoption or derivative · BiotechnologySEC FORM 4 Code A—193,957 at $0.00filing
15 Sep 2026filed 18 Sep 2026WHWK Whitehawk Therapeuticsoption or derivative · BiotechnologySEC FORM 4 Code A—193,957 at $0.00filing
15 Sep 2026filed 15 Sep 2026WHWK Whitehawk Therapeuticsoption or derivative · BiotechnologySEC FORM 4 Code A—193,957 at $0.00filing
15 Sep 2026filed 15 Sep 2026WHWK Whitehawk Therapeuticsoption or derivative · BiotechnologySEC FORM 4 Code A—193,957 at $0.00filing
15 Sep 2026filed 15 Sep 2026WHWK Whitehawk Therapeuticsoption or derivative · BiotechnologySEC FORM 4 Code A—193,957 at $0.00filing
15 Sep 2026filed 15 Sep 2026WHWK Whitehawk Therapeuticsoption or derivative · BiotechnologySEC FORM 4 Code A—193,957 at $0.00filing
14 May 2026filed 18 May 2026WHWK Whitehawk TherapeuticsBiotechnologySEC FORM 4 Code A$200K51,021 at $3.92filing
14 May 2026filed 18 May 2026WHWK Whitehawk TherapeuticsBiotechnologySEC FORM 4 Code A$200K51,021 at $3.92filing
9 Apr 2026filed 10 Apr 2026WHWK Whitehawk TherapeuticsBiotechnologySEC FORM 4 Sold$49K14,500 at $3.38filing
9 Apr 2026filed 10 Apr 2026WHWK Whitehawk TherapeuticsBiotechnologySEC FORM 4 Sold$49K14,500 at $3.38filing
8 Apr 2026filed 8 Apr 2026WHWK Whitehawk TherapeuticsBiotechnologySEC FORM 4 Sold$217K63,945 at $3.40filing
8 Apr 2026filed 8 Apr 2026WHWK Whitehawk TherapeuticsBiotechnologySEC FORM 4 Sold$217K63,945 at $3.40filing
7 Apr 2026filed 8 Apr 2026WHWK Whitehawk TherapeuticsBiotechnologySEC FORM 4 Sold$323K94,087 at $3.43filing
7 Apr 2026filed 8 Apr 2026WHWK Whitehawk TherapeuticsBiotechnologySEC FORM 4 Sold$323K94,087 at $3.43filing
6 Apr 2026filed 8 Apr 2026WHWK Whitehawk TherapeuticsBiotechnologySEC FORM 4 Sold$359K102,395 at $3.51filing
6 Apr 2026filed 8 Apr 2026WHWK Whitehawk TherapeuticsBiotechnologySEC FORM 4 Sold$359K102,395 at $3.51filing
2 Apr 2026filed 3 Apr 2026WHWK Whitehawk TherapeuticsBiotechnologySEC FORM 4 Sold$93K26,858 at $3.48filing
2 Apr 2026filed 3 Apr 2026WHWK Whitehawk TherapeuticsBiotechnologySEC FORM 4 Sold$93K26,858 at $3.48filing

News

Sectors

Health Care8

Buys in green, sells in red, by the company’s sector.

Related people

Margaret DuganChief Medical Officer · Chief Medical Officer at Whitehawk Therapeutics, filing Form 4 there in the last year
Scott M. GiacobelloChief Financial Officer · Chief Financial Officer at Whitehawk Therapeutics, filing Form 4 there in the last year
Bryan BallOfficer · Insider at Whitehawk Therapeutics, filing Form 4 there in the last year
David DornanChief Scientific Officer · Chief Scientific Officer at Whitehawk Therapeutics, filing Form 4 there in the last year
Vijay K. IyengarDirector · Director at Whitehawk Therapeutics, filing Form 4 there in the last year